Macquarie Group’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19.6M | Sell |
905,285
-29,327
| -3% | -$636K | 0.02% | 673 |
|
|
2025
Q1 | $22.7M | Buy |
934,612
+251,960
| +37% | +$6.11M | 0.03% | 629 |
|
|
2024
Q4 | $14.2M | Buy |
+682,652
| New | +$14.2M | 0.02% | 733 |
|
|
2022
Q4 | – | Sell |
-186,900
| Closed | -$2.42M | – | 1889 |
|
|
2022
Q3 | $2.42M | Sell |
186,900
-2,011
| -1% | -$26.1K | ﹤0.01% | 1164 |
|
|
2022
Q2 | $1.32M | Hold |
188,911
| – | – | ﹤0.01% | 1410 |
|
|
2022
Q1 | $1.57K | Sell |
188,911
-600
| -0.3% | -$5 | ﹤0.01% | 1440 |
|
|
2021
Q4 | $1.28M | Sell |
189,511
-23,495
| -11% | -$159K | ﹤0.01% | 1505 |
|
|
2021
Q3 | $1.13M | Buy |
213,006
+2,200
| +1% | +$11.7K | ﹤0.01% | 1554 |
|
|
2021
Q2 | $1.21M | Buy |
210,806
+85,216
| +68% | +$490K | ﹤0.01% | 1559 |
|
|
2021
Q1 | $579K | Sell |
125,590
-9,237
| -7% | -$42.6K | ﹤0.01% | 1503 |
|
|
2020
Q4 | $451K | Hold |
134,827
| – | – | ﹤0.01% | 1468 |
|
|
2020
Q3 | $401K | Buy |
134,827
+112,073
| +493% | +$333K | ﹤0.01% | 1448 |
|
|
2020
Q2 | $105K | Buy |
+22,754
| New | +$105K | ﹤0.01% | 1735 |
|
|
2018
Q1 | – | Sell |
-2,100
| Closed | -$8K | – | 2204 |
|
|
2017
Q4 | $8K | Buy |
+2,100
| New | +$8K | ﹤0.01% | 2303 |
|